Clinical trial
HIV Risk Reduction and Drug Abuse Treatment in Iran
NCT00398008 · Yale University, Other · Withdrawn
Key facts
| NCT number | NCT00398008 |
|---|---|
| Title | HIV Risk Reduction and Drug Abuse Treatment in Iran |
| Official title | HIV Risk Reduction and Drug Abuse Treatment in Iran |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opiate Dependence, HIV Infections |
| Intervention type | Behavioral, Drug |
| Interventions | Buprenorphine/Subutex, Naltrexone, Drug counseling |
| Enrollment | 0 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Nov 10, 2006 |
| Last update posted | Mar 30, 2020 |
| Countries | Iran, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: